BREYANZI has significant market potential due to its innovative approach as a CD19-directed chimeric antigen receptor (CAR) T-cell therapy. The growing prevalence of hematologic malignancies ...

DelveInsight's 'BREYANZI Market Size, Forecast, and Market Insight Report' highlights the details around BREYANZI, a CD19-directed CAR ...

In a preclinical study, researchers at Children's Hospital of Philadelphia (CHOP) demonstrated a novel gene therapy with potentially increased effectiveness and safety for the treatment for ...

FDA has provided input on key elements of the SER-155 allo-HSCT clinical development plans including support for the proposed primary efficacy ...

Data published in NEJM Evidence detail the first clinical test of ZSCAN4 for telomere elongation.Treatment with EXG-34217 resulted in in vivo ...

Now, he is trying to raise £45,500 for haematopoietic stem cell transplantation (HSCT), a high-risk treatment that aims to "reset" the immune system by destroying it and regrowing it using stem ...

Sometimes, blood can pool in the heart and form clots, which could lead to a stroke. You have treatment options if your symptoms become too severe. Treatment for AFib, such as medications ...

When Mr. Kristof’s friend Drew sought prison for treatment, he was desperate for help. Jail just happened to be the option in front of him. This illustrates just how out of reach addiction ...

AlloHeme test accurately predicts relapse post-allo-HSCT in AML and MDS, with a median lead time of 36 days. The ACROBAT study involved 287 patients, showing significant predictive value of ...

The £50,000 was duly raised, and Rayanne flew off to Mexico hoping that the revolutionary HSCT treatment which uses stem cells, would help regain her life away from MS. As she explains, the treatment ...